PNPreecha Nootim

Preecha Nootim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Preecha Nootim has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cannabis Oil and Exploratory Gut–Immune Signatures During Breast Cancer Chemotherapy: A Randomized Pilot Trial

    by May Soe Thu, Thunnicha Ondee, Barry J. Campbell, Joanne L. Fothergill, Mawin Vongsaisuwon, Chanida Vinayanuwattikun, Kamonwan Banchuen, Sunchai Payungporn, Phanupong Phutrakool, Preecha Nootim, et al.

    Background: Approximately 42% of breast cancer patients report cannabis use for chemotherapy-related symptom relief, yet its impact on the gut–immune axis remains unexplored. This trial evaluated the feasibility of monitoring short-chain fatty acids (SCFAs) and systemic cytokines as exploratory biomarkers during cannabis oil intervention. Method: In a double-blind, placebo-controlled pilot trial, women with breast cancer (n = 10) receiving chemotherapy were randomized to cannabis oil (n = 6) or placebo (n = 4) for 12 weeks. Fecal SCFAs and plasma cytokines were analyzed in paired samples. Results: Dietary stability was systematically assessed using a food frequency questionnaire, with stability defined as 0.05), were observed in both exploratory endpoints. Fecal short-chain fatty acid profiling revealed a descriptive numerical reduction in the proteolytic dysbiosis marker iso-butyric acid within the cannabis arm compared with a marginal increase in placebo. Directionally, the cannabis group demonstrated greater median reductions in inflammatory cytokines such as IL-6, IL-8, IL-1β, and TNF-⍺ whereas the placebo group exhibited persistent or heterogeneous profiles. Conclusions: These directional trends toward reduced proteolytic metabolites and attenuated systemic cytokines suggest possible associations between cannabis oil exposure and exploratory gut microbial and immune biomarkers. Given the small pilot sample size, these hypothesis-generating findings lack formal statistical power but warrant adequately powered confirmatory trials.

  • Open Access

    Efficacy of Hibiscus sabdariffa L. extract on metabolic parameters in participants with abdominal obesity and mild metabolic syndrome in Bangkok, Thailand: A double-blind, randomized, placebo-controlled trial

    by Kanchaporn Chaisungnern, Thanapoom Rattananupong, Rossukon Klinhom, Srisuphak Nanta, Kamonwan Banchuen, Arunporn Itharat, Pranporn Kuropakornpong, Thanan Supasiri, Preecha Nootim, Wiroj Jiamjarasrangsi


  • Open Access

    The Effects of 12-Week Traditional Thai Exercise (Ruesi Dadton) on Glycemic Control and Inflammatory Markers in Prediabetes: A Randomized Controlled Trial

    by Pornchai Sawangwong, Sucharat Tungsukruthai, Preecha Nootim, Kusuma Sriyakul, Pratya Phetkate, Kammal Kumar Pawa, Parunkul Tungsukruthai

    Hyperglycemia and inflammation are hallmarks of the prediabetes stage, which has the potential to develop into diabetes mellitus. In this stage, lifestyle changes and exercise are recommended and have been shown to be effective. However, there has been insufficient study investigating the impact of Ruesi Dadton (RD) exercise on prediabetes. Therefore, this study aimed to investigate the effect of RD exercise on biomarkers of glycemic level including fasting plasma glucose (FPG), the 2 h oral glucose tolerance test (OGTT), hemoglobin A1C (HbA1C), the biomarkers of inflammation C-reactive protein (CRP) and interleukin 6 (IL-6), and body mass index (BMI) on prediabetes during 12-week RD exercise. A total of 64 participants were randomly assigned into two groups, RD and control (CON), and were tested by measuring their glycemic levels to screen for prediabetes. The RD group was instructed to perform 10 postures of RD exercise in 60 min, three times a week. The CON group received standard lifestyle recommendations that were not pharmacologically managed. The results reveal that the RD group experienced a significant decrease in FPG, OGTT, HbA1C, and IL-6 (p < 0.01), and BMI and CRP (p < 0.05) compared to the CON group. In addition, the CON group had considerably higher glycemic levels, BMI and IL-6 levels (p < 0.01). Our study demonstrates that RD could decrease the biomarkers of glycemic level and inflammation during 12 weeks of RD exercise in prediabetes. These findings suggest that RD exercise is an effective approach for reducing systemic inflammation and controlling glycemic levels in prediabetic patients.